Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Balvi Fund is a scientific investment and grant-giving organization established by Vitalik Buterin to support high-impact projects in pandemic preparedness and biosecurity. The fund focuses on neglected areas of research, including mucosal vaccines, air quality improvements such as Far-UVC light and ventilation, and the development of open-source medical technologies. By leveraging crypto-assets, Balvi provides rapid funding to academic institutions and biotech startups working on global health challenges. Its portfolio includes diverse initiatives aimed at preventing future pandemics and improving public health infrastructure. The organization operates with a focus on speed and scientific merit, often funding projects that traditional institutional funders might overlook.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Balvi Fund.